ECOG A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer Adult CIRB - Late Phase Emphasis Closed to Accrual. Pts Still Rcving Intervention Available to Open